Experience reference and China's path of legislation on orphan drugs and medical devicesXU Ying-ling, YANG Yue2017-2026
A review of China's rare disease drug policies and their implementation effectivenessCUI Na, LIU Kai, DONG Quan-liang, TIAN Li-juan2027-2035
Practice and consideration on the management of human genetic resources in drug clinical research under new regulationsNI Qi, LIU Yi2036-2040
Physiopathologic role of the proteasome and progress in the development of targeted drugsZUO Rui, ZHOU Qiu-hua, JI Xiao-jun, SU Jin-cai, XU Dan, WU Jian2041-2048
The current situation,difficulties,and countermeasures of ethical review for termination of clinical trialsZHAO Xiao-yu, ZHOU Ji-yin2049-2056
Clinical research progress on the impact of esketamine on the postoperative recovery quality in adult patienceGENG Zhi-yu, BAI Ming-xin2057-2061
Application of organoids in endometrial physiological models,disease mechanisms and therapeutic researchTIAN Shu-ting, LIU Li, DENG Yi-fang2062-2067
Prediction on the mechanism of agarwood sesquiterpene components in prevention and treatment of insomnia based on molecular dockingWANG Can-hong, GONG Bao, WU Yu-lan, MOU Jun-yu, CHENG Xiao-ling, WEI Jian-he2068-2075
Effect of Massa Medicata Fermentata on gastrointestinal hormones and intestinal flora in mice with spleen deficiency constipation based on network pharmacologyLIANG Xue-juan, CHEN Ling-long, FENG Xiao-long, LIU Ju-li, PENG Yan-mei, TIAN Qi-xue2076-2086
Determination of aerodynamic particle size distribution of revefenacin inhalation solutionCAO Ting, WANG Xue, YUAN Dan, ZHAO Wen-jie, WANG Min, LIU A-li2087-2093